Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.
Journal: ChemMedChem
Published: January 25, 2024
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: February 09, 2023
DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: November 05, 2022
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: October 07, 2020
Hydrophilic interaction liquid chromatography-tandem mass spectrometric approach for simultaneous determination of safingol and D-erythro-sphinganine in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: December 19, 2018
Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Journal: Anti-cancer drugs
Published: October 02, 2018
Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 25, 2017
P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Journal: International journal of cancer
Published: October 05, 2016
Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
Journal: Molecular cancer therapeutics
Published: March 16, 2016
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
Journal: BMC research notes
Published: March 19, 2014
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
Journal: Pediatric blood & cancer
Published: February 16, 2013
Last Updated: 09/26/2026